Skip to main content
NCBI home page
American Journal of Public Health logoLink to American Journal of Public Health
. 1994 Feb;84(2):275–281. doi: 10.2105/ajph.84.2.275

Injecting risk behavior among drug users in Amsterdam, 1986 to 1992, and its relationship to AIDS prevention programs.

E J van Ameijden 1, A R van den Hoek 1, R A Coutinho 1
PMCID: PMC1614996  PMID: 8296953

Abstract

OBJECTIVES. Serial, cross-sectional trends in injecting risk behavior were studied among drug users from 1986 to 1992. METHODS. From a cohort study in Amsterdam, 616 intake visits of drug users who had injected in the 6 months preceding intake were selected. RESULTS. The proportion of drug users who reported borrowing and lending used injection equipment and reusing needles/syringes (in the previous 6 months), continuously declined from 51% to 20%, from 46% to 10% and from 63% to 39%, respectively. In multivariate analysis, it appeared unlikely that a selective recruitment of participants over time was responsible for these trends. Participants, recruited later in time, had been previously tested for human immunodeficiency virus (HIV) more often, had received daily methadone less often, and had obtained a higher proportion of new needles via exchange programs. Indications were found that (1) voluntary HIV testing and counseling leads to less borrowing, lending, and reusing equipment; and (2) obtaining needles via exchange programs leads to less reusing needles/syringes. It appeared that nonattenders of methadone and exchange programs have reduced borrowing and lending to the same extent as attenders. CONCLUSIONS. Methodologically, evaluating specific measures is difficult. However, the combination of various preventive measures in Amsterdam is likely to be responsible for the observed decrease in injecting risk behavior.

Full text

PDF
275

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Battjes R. J., Pickens R. W., Amsel Z. HIV infection and AIDS risk behaviors among intravenous drug users entering methadone treatment in selected U.S. cities. J Acquir Immune Defic Syndr. 1991;4(11):1148–1154. [PubMed] [Google Scholar]
  2. Blower S. Behaviour change and stabilization of seroprevalence levels in communities of injecting drug users: correlation or causation? J Acquir Immune Defic Syndr. 1991;4(9):920–923. [PubMed] [Google Scholar]
  3. Buning E. C., Coutinho R. A., van Brussel G. H., van Santen G. W., van Zadelhoff A. W. Preventing AIDS in drug addicts in Amsterdam. Lancet. 1986 Jun 21;1(8495):1435–1435. doi: 10.1016/s0140-6736(86)91570-9. [DOI] [PubMed] [Google Scholar]
  4. Buning E. C., Van Brussel G. H., Van Santen G. The 'methadone by bus' project in Amsterdam. Br J Addict. 1990 Oct;85(10):1247–1250. doi: 10.1111/j.1360-0443.1990.tb01598.x. [DOI] [PubMed] [Google Scholar]
  5. Calsyn D. A., Saxon A. J., Freeman G., Jr, Whittaker S. Ineffectiveness of AIDS education and HIV antibody testing in reducing high-risk behaviors among injection drug users. Am J Public Health. 1992 Apr;82(4):573–575. doi: 10.2105/ajph.82.4.573. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Chaisson R. E., Osmond D., Moss A. R., Feldman H. W., Bernacki P. HIV, bleach, and needle sharing. Lancet. 1987 Jun 20;1(8547):1430–1430. doi: 10.1016/s0140-6736(87)90615-5. [DOI] [PubMed] [Google Scholar]
  7. Des Jarlais D. C., Abdul-Quader A., Tross S. The next problem: maintenance of AIDS risk reduction among intravenous drug users. Int J Addict. 1991 Dec;26(12):1279–1292. doi: 10.3109/10826089109062160. [DOI] [PubMed] [Google Scholar]
  8. Des Jarlais D. C., Friedman S. R. HIV and intravenous drug use. AIDS. 1988;2 (Suppl 1):S65–S69. doi: 10.1097/00002030-198800001-00010. [DOI] [PubMed] [Google Scholar]
  9. Farley T. A., Cartter M. L., Wassell J. T., Hadler J. L. Predictors of outcome in methadone programs: effect of HIV counseling and testing. AIDS. 1992 Jan;6(1):115–121. doi: 10.1097/00002030-199201000-00016. [DOI] [PubMed] [Google Scholar]
  10. Grund J. P., Kaplan C. D., Adriaans N. F., Blanken P. Drug sharing and HIV transmission risks: the practice of frontloading in the Dutch injecting drug user population. J Psychoactive Drugs. 1991 Jan-Mar;23(1):1–10. doi: 10.1080/02791072.1991.10472569. [DOI] [PubMed] [Google Scholar]
  11. Guydish J. R., Abramowitz A., Woods W., Black D. M., Sorensen J. L. Changes in needle sharing behavior among intravenous drug users: San Francisco, 1986-88. Am J Public Health. 1990 Aug;80(8):995–997. doi: 10.2105/ajph.80.8.995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Hartgers C., van Ameijden E. J., van den Hoek J. A., Coutinho R. A. Needle sharing and participation in the Amsterdam Syringe Exchange program among HIV-seronegative injecting drug users. Public Health Rep. 1992 Nov-Dec;107(6):675–681. [PMC free article] [PubMed] [Google Scholar]
  13. Hartgers C., van den Hoek A., Krijnen P., Coutinho R. A. HIV prevalence and risk behavior among injecting drug users who participate in "low-threshold" methadone programs in Amsterdam. Am J Public Health. 1992 Apr;82(4):547–551. doi: 10.2105/ajph.82.4.547. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Higgins D. L., Galavotti C., O'Reilly K. R., Schnell D. J., Moore M., Rugg D. L., Johnson R. Evidence for the effects of HIV antibody counseling and testing on risk behaviors. JAMA. 1991 Nov 6;266(17):2419–2429. [PubMed] [Google Scholar]
  15. Käll K. I., Olin R. G. HIV status and changes in risk behaviour among intravenous drug users in Stockholm 1987-1988. AIDS. 1990 Feb;4(2):153–157. doi: 10.1097/00002030-199002000-00009. [DOI] [PubMed] [Google Scholar]
  16. Longshore D., Anglin M. D., Annon K., Hsieh S. Trends in self-reported HIV risk behavior: injection drug users in Los Angeles. J Acquir Immune Defic Syndr. 1993 Jan;6(1):82–90. [PubMed] [Google Scholar]
  17. Magura S., Siddiqi Q., Shapiro J., Grossman J. I., Lipton D. S., Marion I. J., Weisenfeld L., Amann K. R., Koger J. Outcomes of an AIDS prevention program for methadone patients. Int J Addict. 1991 Jun;26(6):629–655. doi: 10.3109/10826089109058910. [DOI] [PubMed] [Google Scholar]
  18. Mientjes G. H., van Ameijden E. J., van den Hoek A. J., Coutinho R. A. Increasing morbidity without rise in non-AIDS mortality among HIV-infected intravenous drug users in Amsterdam. AIDS. 1992 Feb;6(2):207–212. doi: 10.1097/00002030-199202000-00012. [DOI] [PubMed] [Google Scholar]
  19. Nicolosi A., Molinari S., Musicco M., Saracco A., Ziliani N., Lazzarin A. Positive modification of injecting behavior among intravenous heroin users from Milan and northern Italy 1987-1989. NISDA Study. Br J Addict. 1991 Jan;86(1):91–102. doi: 10.1111/j.1360-0443.1991.tb02632.x. [DOI] [PubMed] [Google Scholar]
  20. Robert C. F., Déglon J. J., Wintsch J., Martin J. L., Perrin L., Bourquin M., Gabriel V., Hirschel B. Behavioural changes in intravenous drug users in Geneva: rise and fall of HIV infection, 1980-1989. AIDS. 1990 Jul;4(7):657–660. [PubMed] [Google Scholar]
  21. Sasse H., Salmaso S., Conti S. Risk behaviors for HIV-1 infection in Italian drug users: report from a multicenter study. First Drug User Multicenter Study Group. J Acquir Immune Defic Syndr. 1989;2(5):486–496. [PubMed] [Google Scholar]
  22. Van Ameijden E. J., Van den Hoek J. A., Mientjes G. H., Coutinho R. A. A longitudinal study on the incidence and transmission patterns of HIV, HBV and HCV infection among drug users in Amsterdam. Eur J Epidemiol. 1993 May;9(3):255–262. doi: 10.1007/BF00146260. [DOI] [PubMed] [Google Scholar]
  23. Vanichseni S., Choopanya K., Des Jarlais D. C., Plangsringarm K., Sonchai W., Carballo M., Friedmann P., Friedman S. R. HIV testing and sexual behavior among intravenous drug users in Bangkok, Thailand. J Acquir Immune Defic Syndr. 1992;5(11):1119–1123. [PubMed] [Google Scholar]
  24. Watters J. K., Downing M., Case P., Lorvick J., Cheng Y. T., Fergusson B. AIDS prevention for intravenous drug users in the community: street-based education and risk behavior. Am J Community Psychol. 1990 Aug;18(4):587–596. doi: 10.1007/BF00938061. [DOI] [PubMed] [Google Scholar]
  25. van Ameijden E. J., van den Hoek J. A., van Haastrecht H. J., Coutinho R. A. The harm reduction approach and risk factors for human immunodeficiency virus (HIV) seroconversion in injecting drug users, Amsterdam. Am J Epidemiol. 1992 Jul 15;136(2):236–243. doi: 10.1093/oxfordjournals.aje.a116489. [DOI] [PubMed] [Google Scholar]
  26. van Haastrecht H. J., van den Hoek J. A., Bardoux C., Leentvaar-Kuypers A., Coutinho R. A. The course of the HIV epidemic among intravenous drug users in Amsterdam, The Netherlands. Am J Public Health. 1991 Jan;81(1):59–62. doi: 10.2105/ajph.81.1.59. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. van den Hoek J. A., Coutinho R. A., van Haastrecht H. J., van Zadelhoff A. W., Goudsmit J. Prevalence and risk factors of HIV infections among drug users and drug-using prostitutes in Amsterdam. AIDS. 1988 Feb;2(1):55–60. doi: 10.1097/00002030-198802000-00010. [DOI] [PubMed] [Google Scholar]
  28. van den Hoek J. A., van Haastrecht H. J., Coutinho R. A. Little change in sexual behavior in injecting drug users in Amsterdam. J Acquir Immune Defic Syndr. 1992;5(5):518–522. [PubMed] [Google Scholar]
  29. van den Hoek J. A., van Haastrecht H. J., Coutinho R. A. Risk reduction among intravenous drug users in Amsterdam under the influence of AIDS. Am J Public Health. 1989 Oct;79(10):1355–1357. doi: 10.2105/ajph.79.10.1355. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from American Journal of Public Health are provided here courtesy of American Public Health Association

RESOURCES